世界のin situハイブリダイゼーション(ISH)市場2023-2030:技術別、プローブ別、製品別、用途別、エンドユーザー別、地域別

【英語タイトル】In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology, By Probe, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料(GRV23JN048)・商品コード:GRV23JN048
・発行会社(調査会社):Grand View Research
・発行日:2022年12月30日
・ページ数:180
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,360,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

Grand View Research社は、世界のin situハイブリダイゼーション(ISH)市場規模が、2023年から2030年の間に年平均0.069%成長し、2030年までに24.2億ドルへ達すると予測しています。当調査レポートでは、in situハイブリダイゼーション(ISH)の世界市場を調査対象とし、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、技術種類別(蛍光in situハイブリダイゼーション(FISH)、発色in situハイブリダイゼーション(CISH))分析、プローブ別(DNA、RNA)分析、製品別(器具、キット・プローブ、ソフトウェア、サービス)分析、用途別(がん、細胞遺伝学、発生生物学、感染症、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競合状況などを整理しました。なお、当レポートに掲載されている企業情報には、Thermo Fisher Scientific Inc.、Abbott (Abbott Molecular)、Perkinelmer, Inc.、Bioview、Agilent Technologies, Inc.、Merck Kgaa、Bio-Rad Laboratories, Inc.、Oxford Gene Technology Ip Limited、Leica Biosystems Nussloch Gmbh、F. Hoffman-La Roche Limitedなどが含まれています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・世界のin situハイブリダイゼーション(ISH)市場規模:技術種類別
- 蛍光in situハイブリダイゼーション(FISH)の市場規模
- 発色in situハイブリダイゼーション(CISH)の市場規模
・世界のin situハイブリダイゼーション(ISH)市場規模:プローブ別
- DNAプローブにおける市場規模
- RNAプローブにおける市場規模
・世界のin situハイブリダイゼーション(ISH)市場規模:製品別
- in situハイブリダイゼーション(ISH)器具の市場規模
- in situハイブリダイゼーション(ISH)キット・プローブの市場規模
- in situハイブリダイゼーション(ISH)ソフトウェアの市場規模
- in situハイブリダイゼーション(ISH)サービスの市場規模
・世界のin situハイブリダイゼーション(ISH)市場規模:用途別
- がんにおける市場規模
- 細胞遺伝学における市場規模
- 発生生物学における市場規模
- 感染症における市場規模
- その他用途における市場規模
・世界のin situハイブリダイゼーション(ISH)市場規模:地域別
- 北米のin situハイブリダイゼーション(ISH)市場規模
- ヨーロッパのin situハイブリダイゼーション(ISH)市場規模
- アジア太平洋のin situハイブリダイゼーション(ISH)市場規模
- 中南米のin situハイブリダイゼーション(ISH)市場規模
- 中東・アフリカのin situハイブリダイゼーション(ISH)市場規模
・競合状況

in situハイブリダイゼーション(ISH)市場の成長と動向

Grand View Research, Inc.の最新レポートによると、in situハイブリダイゼーション(ISH)の世界市場規模は2030年までに24億2000万米ドルに達すると予測され、2023年から2030年までの年平均成長率は6.9%で拡大する見込みです。in situハイブリダイゼーション(ISH)は、診断の研究および臨床応用に広く利用されています。ISHは、特定の核酸の分布と標的遺伝子タンパク質産物の関係を決定するのに役立つため、研究者の間で人気のあるアプローチです。それゆえ、ISHの応用範囲の拡大は加速しており、さらなる研究につながっています。

ISH技術とその使用法についての認知度の高まりは、研究者が様々な用途にISH技術を採用することを後押ししています。例えば、MultiplexDXのCEOはElsevierとのインタビューで、FISH技術は早期薬剤開発や個別化治療のための画期的な情報に貢献できると述べています。先進国では意識の高まりから個別化治療を選択する人が増えており、市場の需要を押し上げています。

さらに、先進国では保険償還制度が利用できるようになり、この診断に対する需要が増加しています。最近の保険適用拡大により、国民の大多数が治療を受けられるようになったため、需要は増加の一途をたどっています。例えば、米国ではメディケアが最大の市場プレーヤーであり、所得や病歴に関係なく65歳以上の高齢者に治療を提供しています。

COVID-19の大流行により、様々な研究者がCOVID-19感染細胞にISH技術を採用したため、需要サイドはISH市場に好影響を示しました。2020年7月に発表された研究では、COVID-19感染患者の剖検肺8例、腎生検10例、胎盤1例をISHアッセイとRNAプローブで検討しました。

COVID-19陽性の結果は、ISHによって8つの肺すべてと胎盤で示されたが、腎臓サンプルでは示されませんでした。このアッセイは、組織サンプルからウイルスを検出する高感度で特異的な技術を示すものです。同様に、Advanced Cell Diagnostics, Inc.はCOVID-19研究をサポートするRNAscope技術を導入しました。

各社の戦略的イニシアチブの高まりがISH市場の成長を後押しすると予想されます。主要企業はポートフォリオを強化するため、市場に新製品を投入しています。例えば、F. Hoffmann-La Rocheは2021年3月、in situハイブリダイゼーションと免疫組織化学の多重化機能を拡張するDISCOVERY Green HRP発色検出キットを発売しました。

一方、分子診断学は正確で効果的な結果を提供し、診断の分野で不可欠な用途です。しかし、FISHアッセイの製造コストが高く、FISHイメージングに使用される専門的な組立工場や機器のメンテナンスに多額の資本が必要なため、収益創出が制限される可能性が高いです。

in situハイブリダイゼーション(ISH)市場レポートのハイライト

– 技術別では、CISH分野が予測期間中に最も速い成長率で拡大すると予測されます。CISHで使用される試薬はより安定しているため、サンプルはより長期間保存でき、複数回の検査が可能です。

– プローブ別では、DNAセグメントが予測期間中に最も速い成長率を示すと予測されます。遺伝子異常やがんなど、染色体異常に関連する疾患の発生率が増加しているためです。

– 製品別では、サービス分野が2023年から2030年にかけてCAGRが最も急速に成長すると予測されます。品質基準の遵守と業務機能の向上を目的としたアウトソーシングが増加し、有利な成長に貢献するとみられています。

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1 Methodology and Scope
1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Scope & Segment Definition
1.3.1 Technology
1.3.2 Probe
1.3.3 Product
1.3.4 End-Use
1.4 Market Model
1.4.1 Market Study, By Company Market Share
1.4.2 Regional Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot, 2022
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Segmentation And Scope
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related/Ancillary Market Outlook
3.3 Market Trends And Outlook
3.4 Market Dynamics
3.4.1 Market Driver Analysis
3.4.1.1 Rising Prevalence Of Target Disorders
3.4.1.2 Technological Advancements In The Field Of In Vitro Diagnostics
3.4.1.3 Increasing R&D Investments In In Vitro Diagnostics
3.4.2 Market Restraint Analysis
3.4.2.1 High Cost Of ISH
3.4.2.2 Presence Of An Ambiguous Regulatory Framework
3.4.3 Market Opportunity Analysis
3.4.3.1 Increasing Awareness About The Ish Usage
3.4.4 Market Challenge Analysis
3.4.4.1 Highly Skilled Labour-Intensive Product
3.5 Penetration and Growth Prospect Mapping for Application 2022 (USD Million)
3.6 Business Environment Analysis
3.6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 Covid-19 Impact Analysis:
3.7.1 Challenge Analysis
3.7.2 Opportunity Analysis
3.7.3 Key Developments And Activities
Chapter 4 Technology Type Business Analysis
4.1 In Situ Hybridization Market: Technology Movement Analysis
4.2 FISH
4.2.1 In Situ Hybridization Market For FISH, 2018 – 2030 (USD Million)
4.3 CISH
4.3.1 In Situ Hybridization Market For CISH, 2018 – 2030 (USD Million)
Chapter 5 Probe Business Analysis
5.1 In Situ Hybridization Market: Probe Movement Analysis
5.2 DNA
5.2.1 In Situ Hybridization Market For DNA 2018 – 2030 (USD Million)
5.3 RNA
5.3.1 In Situ Hybridization Market For RNA 2018 – 2030 (USD Million)
Chapter 6 Product Business Analysis
6.1 In Situ Hybridization Market: Product Movement Analysis
6.2 Instruments
6.2.1 In Situ Hybridization Market For Instruments, 2018 – 2030 (USD Million)
6.3 Kits And Probes
6.3.1 In Situ Hybridization Market For Kits And Probes, 2018 – 2030 (USD Million)
6.4 Software
6.4.1 In Situ Hybridization Market For Software, 2018 – 2030 (USD Million)
6.5 Services
6.5.1 In Situ Hybridization Market For Services, 2018 – 2030 (USD Million)
Chapter 7 Application Business Analysis
7.1 In Situ Hybridization Market: Application Movement Analysis
7.2 Cancer
7.2.1 Cancer Application For In Situ Hybridization Market, 2018 – 2030 (USD Million)
7.3 Cytogenetics
7.3.1 Cytogenetics Application For In Situ Hybridization Market, 2018 – 2030 (USD Million)
7.4 Developmental Biology
7.4.1 Development Biology Application For In Situ Hybridization Market, 2018 – 2030 (USD Million)
7.5 Infectious Diseases
7.5.1 Infectious Diseases Application For In Situ Hybridization Market, 2018 – 2030 (USD Million)
7.6 Others
7.6.1 Other Applications For In Situ Hybridization Market, 2018 – 2030 (USD Million)
Chapter 8 End-Use Type Business Analysis
8.1 In Situ Hybridization Market: End-Use Movement Analysis
8.2 Hospital & Diagnostics Laboratories
8.2.1 In Situ Hybridization Market For Hospital & Diagnostics Laboratories, 2018 – 2030 (USD Million)
8.3 CROs
8.3.1 In Situ Hybridization Market For CROs, 2018 – 2030 (USD Million)
8.4 Academic Institutes
8.4.1 In Situ Hybridization Market For Academic Institutes, 2018 – 2030 (USD Million)
8.5 Others
8.5.1 In Situ Hybridization Market For Other, 2018 – 2030 (USD Million)
Chapter 9 Regional Business Analysis
9.1 In Situ Hybridization Market Share By Region, 2022 & 2030
9.2 North America
9.2.1 Swot Analysis
9.2.1.1 North America In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.2.1.2 North America In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.2.1.3 North America In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.2.1.4 North America In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.2.1.5 North America In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.2.2 U.S.
9.2.2.1 Key Country Dynamics
9.2.2.2 Target Disease Prevalence
9.2.2.3 Competitive Scenario
9.2.2.4 Regulatory Framework
9.2.2.5 Reimbursement Scenario
9.2.2.6 U.S. In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.2.2.7 U.S. In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.2.2.8 U.S. In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.2.2.9 U.S. In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.2.2.10 U.S. In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.2.3 Canada
9.2.3.1 Key Country Dynamics
9.2.3.2 Target Disease Prevalence
9.2.3.3 Competitive Scenario
9.2.3.4 Regulatory Framework
9.2.3.5 Reimbursement Scenario
9.2.3.6 Canada In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.2.3.7 Canada In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.2.3.8 Canada In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.2.3.9 Canada In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.2.3.10 Canada In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3 Europe
9.3.1 Swot Analysis
9.3.1.1 Europe In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.1.2 Europe In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.1.3 Europe In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.1.4 Europe In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.1.5 Europe In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.2 Germany
9.3.2.1 Key Country Dynamics
9.3.2.2 Target Disease Prevalence
9.3.2.3 Competitive Scenario
9.3.2.4 Regulatory Framework
9.3.2.5 Reimbursement Scenario
9.3.2.6 Germany In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.2.7 Germany In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.2.8 Germany In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.2.9 Germany In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.2.10 Germany In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.3 U.K.
9.3.3.1 Key Country Dynamics
9.3.3.2 Target Disease Prevalence
9.3.3.3 Competitive Scenario
9.3.3.4 Regulatory Framework
9.3.3.5 Reimbursement Scenario
9.3.3.6 U.K. In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.3.7 U.K. In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.3.8 U.K. In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.3.9 U.K. In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.3.10 U.K. In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.4 France
9.3.4.1 Key Country Dynamics
9.3.4.2 Target Disease Prevalence
9.3.4.3 Competitive Scenario
9.3.4.4 Regulatory Framework
9.3.4.5 Reimbursement Scenario
9.3.4.6 France In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.4.7 France In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.4.8 France In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.4.9 France In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.4.10 France In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.5 Italy
9.3.5.1 Key Country Dynamics
9.3.5.2 Target Disease Prevalence
9.3.5.3 Competitive Scenario
9.3.5.4 Regulatory Framework
9.3.5.5 Reimbursement Scenario
9.3.5.6 Italy In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.5.7 Italy In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.5.8 Italy In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.5.9 Italy In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.5.10 Italy In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.6 Spain
9.3.6.1 Key Country Dynamics
9.3.6.2 Target Disease Prevalence
9.3.6.3 Competitive Scenario
9.3.6.4 Regulatory Framework
9.3.6.5 Reimbursement Scenario
9.3.6.6 Spain In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.6.7 Spain In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.6.8 Spain In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.6.9 Spain In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.6.10 Spain In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.7 Denmark
9.3.7.1 Key Country Dynamics
9.3.7.2 Target Disease Prevalence
9.3.7.3 Competitive Scenario
9.3.7.4 Regulatory Framework
9.3.7.5 Reimbursement Scenario
9.3.7.6 Denmark In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.7.7 Denmark In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.7.8 Denmark In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.7.9 Denmark In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.7.10 Denmark In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.9 Sweden
9.3.8.1 Key Country Dynamics
9.3.8.2 Target Disease Prevalence
9.3.8.3 Competitive Scenario
9.3.8.4 Regulatory Framework
9.3.8.5 Reimbursement Scenario
9.3.8.6 Sweden In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.8.7 Sweden In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.8.8 Sweden In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.8.9 Sweden In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.8.10 Sweden In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.3.9 Norway
9.3.9.1 Key Country Dynamics
9.3.9.2 Target Disease Prevalence
9.3.9.3 Competitive Scenario
9.3.9.4 Regulatory Framework
9.3.9.5 Reimbursement Scenario
9.3.9.6 Norway In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.3.9.7 Norway In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.3.9.8 Norway In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.3.9.9 Norway In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.3.9.10 Norway In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4 Asia Pacific
9.4.1 Swot Analysis
9.4.1.1 Asia Pacific In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.1.2 Asia Pacific In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.1.3 Asia Pacific In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.1.4 Asia Pacific In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.1.5 Asia Pacific In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4.2 Japan
9.4.2.1 Key Country Dynamics
9.4.2.2 Target Disease Prevalence
9.4.2.3 Competitive Scenario
9.4.2.4 Regulatory Framework
9.4.2.5 Reimbursement Scenario
9.4.2.6 Japan In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.2.7 Japan In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.2.8 Japan In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.2.9 Japan In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.2.10 Japan In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4.3 China
9.4.3.1 Key Country Dynamics
9.4.3.2 Target Disease Prevalence
9.4.3.3 Competitive Scenario
9.4.3.4 Regulatory Framework
9.4.3.5 Reimbursement Scenario
9.4.3.6 China In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.3.7 China In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.3.8 China In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.3.9 China In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.3.10 China In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4.4 India
9.4.4.1 Key Country Dynamics
9.4.4.2 Target Disease Prevalence
9.4.4.3 Competitive Scenario
9.4.4.4 Regulatory Framework
9.4.4.5 Reimbursement Scenario
9.4.4.6 India In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.4.7 India In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.4.8 India In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.4.9 India In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.4.10 India In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4.5 South Korea
9.4.5.1 Key Country Dynamics
9.4.5.2 Target Disease Prevalence
9.4.5.3 Competitive Scenario
9.4.5.4 Regulatory Framework
9.4.5.5 Reimbursement Scenario
9.4.5.6 South Korea In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.5.7 South Korea In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.5.8 South Korea In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.5.9 South Korea In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.5.10 South Korea In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4.6 Australia
9.3.9.1 Key Country Dynamics
9.4.6.2 Target Disease Prevalence
9.4.6.3 Competitive Scenario
9.4.6.4 Regulatory Framework
9.4.6.5 Reimbursement Scenario
9.4.6.6 Australia In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.6.7 Australia In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.6.8 Australia In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.6.9 Australia In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.6.10 Australia In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.4.7 Thailand
9.4.7.1 Key Country Dynamics
9.4.7.2 Target Disease Prevalence
9.4.7.3 Competitive Scenario
9.4.7.4 Regulatory Framework
9.4.7.5 Reimbursement Scenario
9.4.7.6 Thailand In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.4.7.7 Thailand In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.4.7.8 Thailand In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.4.7.9 Thailand In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.4.7.10 Thailand In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.5 Latin America
9.5.1 Swot Analysis
9.5.1.1 Latin America In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.5.1.2 Latin America In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.5.1.3 Latin America In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.5.1.4 Latin America In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.5.1.5 Latin America In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.5.2 Brazil
9.5.2.1 Key Country Dynamics
9.5.2.2 Target Disease Prevalence
9.5.2.3 Competitive Scenario
9.5.2.4 Regulatory Framework
9.5.2.5 Reimbursement Scenario
9.5.2.6 Brazil In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.5.2.7 Brazil In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.5.2.8 Brazil In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.5.2.9 Brazil In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.5.2.10 Brazil In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.5.3 Mexico
9.5.3.1 Key Country Dynamics
9.5.3.2 Target Disease Prevalence
9.5.3.3 Competitive Scenario
9.5.3.4 Regulatory Framework
9.5.3.5 Reimbursement Scenario
9.5.3.6 Mexico In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.5.3.7 Mexico In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.5.3.8 Mexico In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.5.3.9 Mexico In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.5.3.10 Mexico In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.5.4 Argentina
9.5.4.1 Key Country Dynamics
9.5.4.2 Target Disease Prevalence
9.5.4.3 Competitive Scenario
9.5.4.4 Regulatory Framework
9.5.4.5 Reimbursement Scenario
9.5.4.6 Argentina In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.5.4.7 Argentina In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.5.4.8 Argentina In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.5.4.9 Argentina In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.5.4.10 Argentina In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.6 MEA
9.6.1 Swot Analysis
9.6.1.1 MEA In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.6.1.2 MEA In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.6.1.3 MEA In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.6.1.4 MEA In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.6.1.5 MEA In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.6.2 South Africa
9.6.2.1 Key Country Dynamics
9.6.2.2 Target Disease Prevalence
9.6.2.3 Competitive Scenario
9.6.2.4 Regulatory Framework
9.6.2.5 Reimbursement Scenario
9.6.2.6 South Africa In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.6.2.7 South Africa In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.6.2.8 South Africa In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.6.2.9 South Africa In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.6.2.10 South Africa In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.6.3 Saudi Arabia
9.6.3.1 Key Country Dynamics
9.6.3.2 Target Disease Prevalence
9.6.3.3 Competitive Scenario
9.6.3.4 Regulatory Framework
9.6.3.5 Reimbursement Scenario
9.6.3.6 Saudi Arabia In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.6.3.7 Saudi Arabia In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.6.3.8 Saudi Arabia In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.6.3.9 Saudi Arabia In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.6.3.10 Saudi Arabia In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.6.4 UAE
9.6.4.1 Key Country Dynamics
9.6.4.2 Target Disease Prevalence
9.6.4.3 Competitive Scenario
9.6.4.4 Regulatory Framework
9.6.4.5 Reimbursement Scenario
9.6.4.6 UAE In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.6.4.7 UAE In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.6.4.8 UAE In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.6.4.9 UAE In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.6.4.10 UAE In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
9.6.5 Kuwait
9.6.5.1 Key Country Dynamics
9.6.5.2 Target Disease Prevalence
9.6.5.3 Competitive Scenario
9.6.5.4 Regulatory Framework
9.6.5.5 Reimbursement Scenario
9.6.5.6 Kuwait In Situ Hybridization (ISH) Market, By Technology, 2018 – 2030 (USD Million)
9.6.5.7 Kuwait In Situ Hybridization (ISH) Market, By Probe, 2018 – 2030 (USD Million)
9.6.5.8 Kuwait In Situ Hybridization (ISH) Market, By Product, 2018 – 2030 (USD Million)
9.6.5.9 Kuwait In Situ Hybridization (ISH) Market, By Application, 2018 – 2030 (USD Million)
9.6.5.10 Kuwait In Situ Hybridization (ISH) Market, By End-Use, 2018 – 2030 (USD Million)
Chapter 10 Competitive Landscape
10.1 Participant’s Overview
10.2 Financial Performance
10.3 Participant Categorization
10.3.1 Market Leaders
10.3.1.1 In Situ Hybridization Market Share Analysis, 2022
10.3.1.2 Company Profiles
10.3.1.2.1 Thermo Fisher Scientific Inc.
10.3.1.2.2 Abbott (Abbott Molecular)
10.3.1.2.3 Perkinelmer, Inc.
10.3.1.2.4 Bioview
10.3.1.2.5 Agilent Technologies, Inc.
10.3.1.2.6 Merck Kgaa
10.3.1.2.7 Bio-Rad Laboratories, Inc.
10.3.1.2.8 Oxford Gene Technology Ip Limited
10.3.1.2.9 Leica Biosystems Nussloch Gmbh
10.3.1.2.10 F. Hoffman-La Roche Limited
10.3.1.2.11 Neogenomics Laboratories, Inc.
10.3.1.2.12 Advanced Cell Diagnostics, Inc.
10.3.2 Strategy Mapping
10.3.2.1 Expansion
10.3.2.2 Acquisition
10.3.2.3 Collaborations
10.3.2.4 Product/Service Launch
10.3.2.5 Partnerships
10.3.2.6 Others



★調査レポート[世界のin situハイブリダイゼーション(ISH)市場2023-2030:技術別、プローブ別、製品別、用途別、エンドユーザー別、地域別] (コード:GRV23JN048)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のin situハイブリダイゼーション(ISH)市場2023-2030:技術別、プローブ別、製品別、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆